Aethlon Medical Stock Performance
| AEMD Stock | USD 0.99 0.19 16.10% |
The firm shows a Beta (market volatility) of -0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Aethlon Medical are expected to decrease at a much lower rate. During the bear market, Aethlon Medical is likely to outperform the market. Aethlon Medical has an expected return of -0.84%. Please make sure to confirm Aethlon Medical potential upside and the relationship between the accumulation distribution and period momentum indicator , to decide if Aethlon Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aethlon Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
1 | Aethlon Medical Coverage Initiated at StockNews.com | 02/28/2024 |
2 | Medical Membrane Market Size Share to Surpass USD 10.2 billion by 2031 Analysis by Transparency Market Research, Inc. | 03/07/2024 |
3 | Contrasting T2 Biosystems Aethlon Medical - Defense World | 03/13/2024 |
4 | Insider Trading | 03/22/2024 |
5 | 12 Health Care Stocks Moving In Thursdays Intraday Session - MSN | 03/27/2024 |
6 | Acquisition by Edward Broenniman of 34247 shares of Aethlon Medical subject to Rule 16b-3 | 04/01/2024 |
7 | Acquisition by Guy Cipriani of 120883 shares of Aethlon Medical at 2.52 subject to Rule 16b-3 | 04/08/2024 |
8 | Acquisition by Gikakis Nicolas of 32894 shares of Aethlon Medical at 1.52 subject to Rule 16b-3 | 04/16/2024 |
9 | RNAZ, QBTS and WAVD are among premarket gainers | 05/10/2024 |
10 | AEMD Data From In Vitro Study Supports Advancing Planned Oncology Clinical Trial | 05/13/2024 |
| Begin Period Cash Flow | 17.2 M | |
| Total Cashflows From Investing Activities | -943.1 K |
Aethlon |
Aethlon Medical Relative Risk vs. Return Landscape
If you would invest 173.00 in Aethlon Medical on February 14, 2024 and sell it today you would lose (74.00) from holding Aethlon Medical or give up 42.77% of portfolio value over 90 days. Aethlon Medical is currently does not generate positive expected returns and assumes 3.3688% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Aethlon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aethlon Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aethlon Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aethlon Medical, and traders can use it to determine the average amount a Aethlon Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2486
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AEMD |
Estimated Market Risk
| 3.37 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.84 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aethlon Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aethlon Medical by adding Aethlon Medical to a well-diversified portfolio.
Aethlon Medical Fundamentals Growth
Aethlon Stock prices reflect investors' perceptions of the future prospects and financial health of Aethlon Medical, and Aethlon Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aethlon Stock performance.
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (20.47) % | ||||
| Current Valuation | (3.87 M) | ||||
| Shares Outstanding | 2.63 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 0.52 X | ||||
| Price To Sales | 6.91 X | ||||
| Revenue | 574.25 K | ||||
| EBITDA | (11.76 M) | ||||
| Cash And Equivalents | 14.92 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 1.21 M | ||||
| Debt To Equity | 0.05 % | ||||
| Book Value Per Share | 2.93 X | ||||
| Cash Flow From Operations | (10.51 M) | ||||
| Earnings Per Share | (5.01) X | ||||
| Total Asset | 17.51 M | ||||
| Retained Earnings | (142.36 M) | ||||
| Current Asset | 817 K | ||||
| Current Liabilities | 1.08 M | ||||
About Aethlon Medical Performance
To evaluate Aethlon Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Aethlon Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Aethlon Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Aethlon Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Aethlon's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.Things to note about Aethlon Medical performance evaluation
Checking the ongoing alerts about Aethlon Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aethlon Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aethlon Medical generated a negative expected return over the last 90 days | |
| Aethlon Medical has some characteristics of a very speculative penny stock | |
| Aethlon Medical has high historical volatility and very poor performance | |
| Aethlon Medical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 574.25 K. Net Loss for the year was (12.03 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (10.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| Latest headline from finance.yahoo.com: AEMD Data From In Vitro Study Supports Advancing Planned Oncology Clinical Trial |
- Analyzing Aethlon Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aethlon Medical's stock is overvalued or undervalued compared to its peers.
- Examining Aethlon Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aethlon Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aethlon Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aethlon Medical's stock. These opinions can provide insight into Aethlon Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.